Translational Medicine is the research that transforms scientific discoveries arising from laboratory, clinical or population studies into new clinical tools and applications that improve human and animal health by reducing disease incidence, morbidity and mortality.
Bio-Innovations in Translational Immunology and Applied Microbiology (BITIAM), ISSN: 2601-288X, ISSN-L: 2601-288X is an international peer-reviewed Open Access Journal, featuring original and observational investigations in the broad fields of laboratory, clinical and public health research, aiming to provide practical up-to-date information in significant subjects in immunology and applied microbiology. It is published monthly.
Why publish your article in BITIAM?
Open Access: All articles published by BITIAM are made freely and permanently accessible on line immediately upon publication.
High visibility: BITIAM’s Open Access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication: BITIAM offers a fast publication schedule whilst maintaining rigorous peer review.
Flexibility: On line publication in BITIAM gives you the opportunity to publish large data sets, large number of colour illustrations and moving pictures.
Translational Medical Research is a two-way process. On one hand it concerns the conversion of basic research findings into new approaches for the diagnosis and therapy of disease. On the other hand it involves the conversion of clinical observations into basic research questions that can be addressed through experimentation.
It is focused an ensuring that proven strategies for disease treatment and prevention are actually implemented within the community. The pursuit of Translational Medicine is one of UCSF’s priorities at the beginning of the 21st Century.
The key to any Translational Medicine Initiative is to make sure the advances of the laboratory are finding their way into the lives of patients. The productivity of Translational Research involving infectious diseases relevant to both human and animal health.
Translational Research is where laboratory science and clinical medicine meet to develop novel therapeutics to prevent, diagnose and treat disease. Many diseases that occur in humans are also recognized in non-human species. Highly cited articles fell into three major areas that point to challenges for veterinary research in the
Future: environmental threats to animal and human health, pathogens and zoonosis, and comparative medicine, and pathology.
Translational Research is often associated with clinical trials and is the first step in bringing a new treatment, medication or technique to the market for use in the general population. Animals and Humans share the same environment. Potential health risks for people who work closely with animals are a top priority.
Veterinary research and clinical contributions reach into every aspect of biomedical health and science:
Livestock production and food safety;
Comparative Basic and Translational Research;
Companion Animal Medicine and Surgery;
Animal Welfare and the Human/Animal Bond;
Wildlife and Ecosystem Health.
Companion animal medicine and pathology is the new frontier of translational medicine, engaging both veterinary and medical scientists in the real-world clinical laboratory of naturally occurring disease in animals.
Microbiology ”hottest topics” are genomics and microbiomics, disease mechanisms, therapy of pathogens and biofilm formation. There are style enough single ”protagonists” (such as: Mycobacterium, Rickettsia, Staphylococcus), left that continue to attract a lot of research activity and therefore, also citations.
Translational Medicine is defined by the European Society for Translational Medicine (EUSTM) as an interdisciplinary branch of the biomedical field supported by three main pillars: bench side, bedside and community.
In December 2011, the National Centre for Advancing Translational Science (CNCATS) was established to ”transform the Translational Science Process so that new treatments and cures for disease can be delivered to patients faster”.
BITIAM proposes to facilitate cooperation and interaction among clinical, scientists, academia, industry, governments to enhance research and development of novel and affordable diagnostic tools and treatments for the infection diseases affecting global population.
The scope of this journal, is to improve the global healthcare system and create a bridge across the discovery, development, regulation and utilization spectrum.
The major aims are referred to:
Optimizing and predicting outcomes in specific patients;
How to response to a therapeutic intervention in a particular disease
To combine disciplines, resources, expertise and techniques for promoting enhancements in prevention, diagnostic and therapies;
Therapy development and microbial mechanisms of drug resistance.
Infections and zoonotic diseases intersect with the realities of porous borders, regional conflicts, and a range of agricultural, economic, and political systems that affect veterinary and public health.
These areas stress the global reach of veterinary and medical science, and the strong momentum of the One Health Initiative, which emphasizes interconnectedness between animal, human and environmental health.
They also reflect a growing emphasis on diseases of companion animals, and their expanding role as Translational Models of human disease.